Page last updated: 2024-10-24

peptide metabolic process

Definition

Target type: biologicalprocess

The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. [GOC:go_curators]

The peptide metabolic process encompasses a complex series of biochemical reactions involved in the synthesis, modification, degradation, and transport of peptides. These processes are essential for a multitude of cellular functions, including protein synthesis, signal transduction, and immune response. Here is a detailed breakdown of the key steps involved:

1. **Peptide Synthesis:** Peptides are assembled from amino acids through the process of translation, where mRNA sequences are decoded to create polypeptide chains.

2. **Post-Translational Modifications:** Once synthesized, peptides undergo various modifications, including:
* **Cleavage:** Peptides are often cleaved by specific proteases to generate smaller, functional peptides.
* **Glycosylation:** The attachment of sugar molecules to peptide chains.
* **Phosphorylation:** The addition of phosphate groups, influencing the peptide's activity.
* **Acetylation:** The addition of an acetyl group, often at the N-terminus.

3. **Peptide Degradation:** Peptides are broken down into their constituent amino acids through proteolysis. This is mediated by enzymes like peptidases and proteases.

4. **Peptide Transport:** Peptides are transported across cellular membranes by specific transporter proteins, enabling their movement into different cellular compartments or extracellular spaces.

5. **Peptide Function:** Peptides serve diverse roles, including:
* **Hormones and Growth Factors:** Peptides like insulin and growth hormone regulate various physiological processes.
* **Signal Transduction:** Peptides can act as ligands for cell surface receptors, triggering signaling cascades.
* **Immune Response:** Peptides from pathogens can stimulate the immune system, leading to an immune response.
* **Antimicrobial Agents:** Peptides can exhibit antimicrobial activity, inhibiting the growth of bacteria or viruses.

6. **Peptide Metabolism Regulation:** The peptide metabolic process is tightly regulated by various factors, including:
* **Gene expression:** The synthesis of enzymes involved in peptide metabolism is controlled by gene expression.
* **Cellular environment:** Factors like pH, temperature, and nutrient availability can influence peptide metabolism.

7. **Disruptions in Peptide Metabolism:** Dysregulation of peptide metabolism can contribute to a range of diseases, including:
* **Cancer:** Abnormalities in peptide growth factors can promote tumor growth.
* **Neurological Disorders:** Disruptions in neuropeptide metabolism can contribute to neurodegenerative diseases.
* **Immune Deficiency:** Defects in peptide-mediated immune responses can lead to immunodeficiency.

The peptide metabolic process is intricate and essential for maintaining cellular function and organismal health. Its complexity provides numerous targets for therapeutic intervention in various diseases.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Carboxypeptidase N catalytic chainA carboxypeptidase N catalytic chain that is encoded in the genome of human. [PRO:DNx, UniProtKB:P15169]Homo sapiens (human)
Carboxypeptidase MA carboxypeptidase M that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14384]Homo sapiens (human)
ChymaseA chymase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P23946]Homo sapiens (human)
NeprilysinA neprilysin that is encoded in the genome of human. [PRO:WCB, UniProtKB:P08473]Homo sapiens (human)

Compounds (35)

CompoundDefinitionClassesRoles
bis(5-amidino-2-benzimidazolyl)methanebis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd
thiorphanThiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.N-acyl-amino acid
losartanlosartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
biphenylyltetrazole;
imidazoles
angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
sumatriptansumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sulfonamide;
tryptamines
serotonergic agonist;
vasoconstrictor agent
captoprilcaptopril : A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.

Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
6-chloroindoleindoles
zpckZPCK: alkylates histidine residue at active center of bovine chymotrypsin
sq 28603SQ 28603: a selective neutral endopeptidase inhibitor
kelatorphankelatorphan: inhibitor of enkephalin metabolism; structure given in first source
(3-(n-hydroxy)carboxamido-2-benzylpropanoyl)glycine
2-(4-morpholinyl)-4h-1-benzopyran-4-one2-(4-morpholinyl)-4H-1-benzopyran-4-one: an aminochromone; exhibits both antiproliferative and antichemotactic activity in vitro
cgs 26303CGS 26303: a potent non-peptidic inhibitor of neutral endopeptidase capable of protecting atrial natriuretic peptide from enzymatic degradation; structure given in first source
5-chlorooxindole5-chlorooxindole: structure in first source
bb3497BB3497: peptide deformylase inhibitor; structure in first source
sq 247982-mercaptomethyl-5-guanidinopentanoic acid: structure
2-oxindole2-oxindole: RN given refers to parent cpd; structure

indolin-2-one : An indolinone carrying an oxo group at position 2.
gamma-lactam;
indolinone
bortezomibamino acid amide;
L-phenylalanine derivative;
pyrazines
antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
tosylphenylalanyl chloromethyl ketoneN-tosyl-L-phenylalanyl chloromethyl ketone : The N-tosyl derivative of L-phenylalanyl chloromethyl ketone.

Tosylphenylalanyl Chloromethyl Ketone: An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process.
alpha-chloroketone;
sulfonamide
alkylating agent;
serine proteinase inhibitor
candoxatrilatcandoxatrilat : A dicarboxylic acid monoamide obtained by formal condensation between the amino group of cis-4-aminocyclohexanecarboxylic acid and the cyclopentanecarboxylic acid group of 1-[(2S)-2-carboxy-3-(2-methoxyethoxy)propyl]cyclopentanecarboxylic acid. A potent inhibitor of neutral endopeptidase (NEP, neprilysin, EC 3.4.24.11), it is used as its 2,3-dihydro-1H-inden-5-yl ester prodrug in the treatment of chronic heart failure.

candoxatrilat: USAN lists candoxatrilat (UK-73,967) with RN 123122-54-3
actinoninactinonin: natural hydroxamic acid, pseudopeptide antibiotic isolated from Streptomyces species; structure
phosphoramidonphosphoramidon : A dipeptide isolated from the cultures of Streptomyces tanashiensis.

phosphoramidon: a membrane metallo-endopeptidase & endothelin-converting enzyme inhibitor; thermolysin inhibitor from culture filtrate of Streptomyces tanashiensis; structure
deoxyaldohexose phosphate;
dipeptide
bacterial metabolite;
EC 3.4.24.11 (neprilysin) inhibitor;
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
omapatrilatomapatrilat: structure in first sourcedipeptide
telaprevircyclopentapyrrole;
cyclopropanes;
oligopeptide;
pyrazines
antiviral drug;
hepatitis C protease inhibitor;
peptidomimetic
sitagliptinsitagliptin : A triazolopyrazine that exhibits hypoglycemic activity.triazolopyrazine;
trifluorobenzene
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
environmental contaminant;
hypoglycemic agent;
serine proteinase inhibitor;
xenobiotic
thiorphan
uk 81,252sampatrilat: structure in first source
cgs 35066CGS 35066: an endothelin-converting enzyme-1 inhibitor; structure in first source
n-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamideboceprevir : A synthetic tripeptide consisting of N-(tert-butylcarbamoyl)-3-methyl-L-valyl, a cyclopropyl-fused prolyl and 3-amino-4-cyclobutyl-2-oxobutanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.tripeptide;
ureas
antiviral drug;
hepatitis C protease inhibitor;
peptidomimetic
anabaenopeptin banabaenopeptin B: from cyanobacteria Planktothrix (Oscillatoria) rubescens
mk-7009vaniprevir : An azamacrocyclic compound that is a hepatitis C virus (HCV) NS3/4A protease inhibitor which is approved for the treatment of hepatitis C virus infections in Japan.

vaniprevir: inhibits hepatitis C virus NS3/4a protease
azamacrocycle;
carbamate ester;
cyclopropanes;
N-sulfonylcarboxamide;
pyrrolidinecarboxamide
antiviral drug;
hepatitis C protease inhibitor
delanzomibC-terminal boronic acid peptide;
phenylpyridine;
secondary alcohol;
threonine derivative
antineoplastic agent;
apoptosis inducer;
proteasome inhibitor
6-(3,5-difluoroanilino)-9-(2,2-difluoroethyl)-2-purinecarbonitrile6-aminopurines
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source
rpx7009RPX7009: a beta-lactamase inhibitor; structure in first source
quininibquininib : A styrylquinoline that is trans-2-styrylquinoline in which the the phenyl group has been substituted at position 2 by a hydroxy group. It is an anti-angiogenic compound that exerts a dose-dependent antagonism of the cysteinyl leukotriene pathway, preferentially antagonising cysteinyl leukotriene receptor 1. The major species at pH 7.3

quininib: has antiangiogenic activity; structure in first source
phenols;
styrylquinoline
angiogenesis inhibitor